Gene · 8505
Papers1,648
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,648
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signaling network inhibition by selected traditional Chinese medicine preparations: a novel multi-target paradigm for colorectal cancer therapy. | Front Pharmacol | 2026 | 41800081 | PubTator, text mining | PubMed |
| PARP-2 catalytic activity drives replication-ICL repair in an allele-specific manner during germline development. | PLoS Genet | 2026 | 41785248 | PubTator, text mining | PubMed |
| Meeting abstracts from the Annual Conference "Clinical Genetics of Cancer 2024". | Hered Cancer Clin Pract | 2026 | 41781972 | PubTator, text mining | PubMed |
| HPF1 regulates the formation of FUS-dependent compartments by PARP1 and PARP2 activation on damaged DNA. | Nucleic Acids Res | 2026 | 41773021 | PubTator, text mining | PubMed |
| Yeast as a Platform to Dissect Poly(ADP-Ribose) Polymerase Function from Magnaporthe oryzae and Evaluate PARP Inhibitors. | Int J Mol Sci | 2026 | 41752036 | PubTator, text mining | PubMed |
| Special Issue "Cancer Biology: From Genetic Aspects to Treatment: 1st Edition". | Int J Mol Sci | 2026 | 41752022 | PubTator, text mining | PubMed |
Identification of Paraptosis-Related Renal Cell Carcinoma Subtypes, Construction of a Prognostic Signature, and Determination of Tumor Microenvironment Landscape Using Bioinformatic Analysis and Experimental Verification. | Curr Issues Mol Biol | 2026 | 41751495 | PubTator, text mining | PubMed |
| Synergistic Cellular Toxicity from Inhibition of Poly(ADP-ribose) Glycohydrolase (PARG) and Ubiquitin-Specific Protease 1 (USP1). | Toxics | 2026 | 41745836 | PubTator, text mining | PubMed |
| Tankyrases and Their Binding Proteins: Origins of Their Roles in Diverse Cellular Pathways. | Cells | 2026 | 41744791 | PubTator, text mining | PubMed |
| Cellular strategies for repairing trapped protein-DNA complexes. | Front Pharmacol | 2026 | 41743125 | PubTator, text mining | PubMed |
| Manipulating DNA repair and the DNA damage response to improve cancer therapy. | NAR Cancer | 2026 | 41716447 | PubTator, text mining | PubMed |
| In the diffuse large B-cell lymphoma microenvironment, SIRT1 is upregulated and correlated with a pro-inflammatory macrophage signature and autophagy-related gene expression. | Front Immunol | 2026 | 41716403 | PubTator, text mining | PubMed |
| Non-canonical cell death in neurodegeneration: emerging mechanisms and therapeutic Frontiers. | Apoptosis | 2026 | 41699331 | PubTator, text mining | PubMed |
| The PARG frontier: mechanisms of PAR turnover and opportunities in precision oncology. | Biochem Pharmacol | 2026 | 41651132 | PubTator, text mining | PubMed |
| Methods for the fabrication of polyelectrolyte capsules for different biomedical applications. | Discov Nano | 2026 | 41632406 | PubTator, text mining | PubMed |
| Uncovering genetic interactions in the DNA repair network in response to endogenous damage and ionizing radiation. | Cell Rep | 2026 | 41546867 | PubTator, text mining | PubMed |
| Poly(ADP-ribose) glycohydrolase enforces p21 degradation via dePARylation to promote gastric cancer progression. | J Clin Invest | 2026 | 41538291 | PubTator, text mining | PubMed |
| Protocol for synthesizing and purifying short-length poly(ADP)ribose polymer using fast protein liquid chromatography. | STAR Protoc | 2026 | 41533506 | PubTator, text mining | PubMed |
| PARG regulates the proteasomal degradation of TARG1. | Cell Rep | 2026 | 41499238 | Swiss-Prot, curated | PubMed |
| Anticancer sensitivities and biological characteristics of HCT116 cells resistant to the selective poly(ADP-ribose) glycohydrolase inhibitor. | FEBS Open Bio | 2026 | 41347713 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8505/papers?page=2